122
Participants
Start Date
January 31, 2003
Primary Completion Date
July 31, 2004
Study Completion Date
July 31, 2004
Ramelteon
Ramelteon 16 mg, tablets, orally, once nightly for up to 6 months.
Placebo
Ramelteon placebo-matching tablets, orally, once nightly for up to 6 months
Birmingham
Jasper
Mesa
Peoria
La Palma
Los Angeles
Riverside
San Diego
Denver
Fort Lauderdale
West Palm Beach
Austell
Roswell
Des Moines
Overland Park
Prairie Village
Florence
Wentzville
Kenilworth
South Plainfield
Cincinnati
Columbus
Portland
Ninety Six
Sioux Falls
Austin
Fort Worth
San Angelo
Wichita Falls
Lead Sponsor
Takeda
INDUSTRY